Literature DB >> 2176481

Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type.

J Ghiso1, M Haltia, F Prelli, J Novello, B Frangione.   

Abstract

Familial amyloidosis, Finnish type (FAF), is an inherited form of systemic amyloidosis clinically characterized by cranial neuropathy and lattice corneal dystrophy. We have demonstrated that the protein subunit isolated from amyloid fibrils shows considerable sequence identity with gelsolin, an actin-binding protein. We have purified the amyloid subunit from a second case and further analysed different fractions from the previous one. Sequence analysis shows that, in both cases, the amyloid subunit starts at position 173 of the mature molecule; it has a heterogeneous N-terminus and contains one amino acid substitution, namely asparagine for aspartic acid, at position 15 (gelsolin residue 187), that is due to a guanine-to-adenine transversion corresponding to nucleotide-654 of human plasma gelsolin cDNA. The substitution maps in a fragment with actin-binding activity and is located in a repetitive motif highly conserved among species. Thus FAF is the first human disease known to be caused by an internal abnormal degradation of a gelsolin variant. We designate this variant of gelsolin-associated amyloidosis 'Agel Asn-187'.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176481      PMCID: PMC1149782          DOI: 10.1042/bj2720827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy.

Authors:  G Boysen; G Galassi; Z Kamieniecka; J Schlaeger; W Trojaborg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-11       Impact factor: 10.154

2.  Haplotype analysis of familial amyloidotic polyneuropathy. Evidence for multiple origins of the Val----Met mutation most common to the disease.

Authors:  K Yoshioka; H Furuya; H Sasaki; M J Saraiva; P P Costa; Y Sakaki
Journal:  Hum Genet       Date:  1989-04       Impact factor: 4.132

3.  Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy.

Authors:  J Meretoja
Journal:  Clin Genet       Date:  1973       Impact factor: 4.438

4.  Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types.

Authors:  J Meretoja
Journal:  Ophthalmologica       Date:  1972       Impact factor: 3.250

5.  Three forms of dominant amyloid neuropathy.

Authors:  G H Sack; K W Dumars; K S Gummerson; A Law; V A McKusick
Journal:  Johns Hopkins Med J       Date:  1981-12

6.  The gelsolin (GSN) cDNA clone, from 9q32-34, identifies BclI and StuI RFLPs.

Authors:  D J Kwiatkowski; L Ozelius; D Schuback; J Gusella; X O Breakefield
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

7.  Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin.

Authors:  H L Yin; D J Kwiatkowski; J E Mole; F S Cole
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

8.  Nucleotide sequence of pig plasma gelsolin. Comparison of protein sequence with human gelsolin and other actin-severing proteins shows strong homologies and evidence for large internal repeats.

Authors:  M Way; A Weeds
Journal:  J Mol Biol       Date:  1988-10-20       Impact factor: 5.469

9.  Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases.

Authors:  E Levy; C Lopez-Otin; J Ghiso; D Geltner; B Frangione
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Gelsolin has three actin-binding sites.

Authors:  J Bryan
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

View more
  16 in total

1.  Metalloendoprotease cleavage triggers gelsolin amyloidogenesis.

Authors:  Lesley J Page; Ji Young Suk; Mary E Huff; Hee-Jong Lim; John Venable; John Yates; Jeffery W Kelly; William E Balch
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

Review 2.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

3.  Clinical features and haplotype analysis of newly identified Japanese patients with gelsolin-related familial amyloidosis of Finnish type.

Authors:  Makiko Taira; Hiroyuki Ishiura; Jun Mitsui; Yuji Takahashi; Toshihiro Hayashi; Jun Shimizu; Takashi Matsukawa; Naoko Saito; Kazumasa Okada; Sadatoshi Tsuji; Hiromasa Sawamura; Shiro Amano; Jun Goto; Shoji Tsuji
Journal:  Neurogenetics       Date:  2012-05-24       Impact factor: 2.660

4.  The co-segregation of the MYL2 R58Q mutation in Chinese hypertrophic cardiomyopathy family and its pathological effect on cardiomyopathy disarray.

Authors:  Kunlun Yin; Yi Ma; Hao Cui; Yang Sun; Bianmei Han; Xuewen Liu; Kun Zhao; Wenke Li; Jingjin Wang; Hongyue Wang; Shuiyun Wang; Zhou Zhou
Journal:  Mol Genet Genomics       Date:  2019-05-18       Impact factor: 3.291

5.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred.

Authors:  R Vidal; T Revesz; A Rostagno; E Kim; J L Holton; T Bek; M Bojsen-Møller; H Braendgaard; G Plant; J Ghiso; B Frangione
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

6.  A 109-amino-acid C-terminal fragment of Alzheimer's-disease amyloid precursor protein contains a sequence, -RHDS-, that promotes cell adhesion.

Authors:  J Ghiso; A Rostagno; J E Gardella; L Liem; P D Gorevic; B Frangione
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

Review 7.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

Review 8.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

9.  Lewy bodies are immunoreactive with antibodies raised to gelsolin related amyloid-Finnish type.

Authors:  T Wisniewski; M Haltia; J Ghiso; B Frangione
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

Review 10.  Unifying features of systemic and cerebral amyloidosis.

Authors:  J Ghiso; T Wisniewski; B Frangione
Journal:  Mol Neurobiol       Date:  1994-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.